Tech Center 1600 • Art Units: 1621 1629 1651 1655 1657
This examiner grants 22% of resolved cases
Melenie Lee Gordon is an examiner in Tech Center 1600 and Art Unit 1621. She has managed 218 resolved cases, which show an allowance rate of 22.5 percent. A notable metric for this examiner is the interview lift of 45.3 percent, indicating a substantial increase in the probability of allowance following an interview. This 45.3 percent lift is a critical factor for practitioners to consider when compared to the 22.5 percent baseline allowance rate. Engaging in direct dialogue appears to be a highly impactful strategy for applications in this unit.
The median days to allowance for the 218 resolved cases is 1168. This figure establishes the expected timeframe for reaching a grant in Art Unit 1621. The 22.5 percent allowance rate reflects the prosecution challenge for filings under this examiner's review. Applicants can use the 1168 days to allowance to plan their prosecution budgets. The 45.3 percent interview lift suggests that verbal communication can effectively address the examiner's concerns and lead to an allowance.
In Tech Center 1600, the resolved cases provide the basis for these prosecution metrics. The 1168 days to allowance is the median duration for successful outcomes. Understanding the relationship between the allowance rate and the interview lift helps in developing a targeted strategy. These figures offer a data-grounded view of the examination process. Practitioners should prioritize interviews to maximize their chances of success given the recorded lift.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17607718 | INDUSTRIAL FERMENTATION PROCESS FOR MICROBIAL CELLS USING A FED-BATCH PRE-CULTURE | Non-Final OA | BASF SE |
| 17331723 | ELECTROANALYTICAL DETERMINATION OF LEUKOCYTE ESTERASE | Final Rejection | Board of Regents, the University of Texas System |
| 17796769 | A METHOD FOR ISOLATING A MICROORGANISM | Final Rejection | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED |
| 18441878 | E3 UBIQUITIN LIGASE (UBE3A) PROTEIN TARGETS | Non-Final OA | Hoffmann-La Roche Inc. |
| 18840008 | METHOD FOR CARRYING OUT THE COMBINED OPERATION OF A BIOETHANOL PRODUCTION UNIT AND A BIOGAS UNIT | Non-Final OA | Novozymes A/S |
| 16766189 | Small Enzyme Particles For Interesterification | Final Rejection | Novozymes A/S |
| 17054950 | USE OF GLYCOSIDASES IN THE PRODUCTION OF OLIGOSACCHARIDES | Final Rejection | Chr. Hansen A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy